Contractor intelligence · computed from public award records
MACLEODS PHARMACEUTICALS LIMITED
- Awards won
- 13
- Known value
- USD 5.2M
- First award
- 05 Mar 2008
- Most recent
- 24 Feb 2016
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 13 | USD 5.2M | 24 Feb 2016 |
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- First Line TB Drugs (2014-15, rebid), Schedule III · 24 Feb 2016 · USD 424K · World Bank
- First Line Anti-TB Drugs · 02 Apr 2014 · USD 88K · World Bank
- Adquisicion de Medicamentos 1o y 2o linea de tuberculosis para el programa de Control de Tuberculosis. · 25 Oct 2013 · USD 1.8M · World Bank
- Contract No. KEMSA/KHSSP/SSD ONT 12/2012-2013 Procurement of Pharmaceutical Drugs (Injectables) · 15 Oct 2013 · USD 4K · World Bank
- CONTRACT NO. KEMSA/KHSSP-SSD OIT 2/2011-2013 FOR SUPPLY OF PHARMACEUTICAL DRUGS (INJECTABLES) · 03 Sept 2012 · USD 8K · World Bank
- Acquisition of First Line Drug for the Treatment of Tuberculosis. · 15 Sept 2011 · USD 671K · World Bank
- First Line TB Drugs (2010-11) Schedule V · 03 Jun 2011 · USD 109K · World Bank
- Procurement of Drugs of 2# line for the Treatment of Tuberculosis. · 02 Nov 2010 · USD 27K · World Bank
- Supply of Second Line Anti TB Drugs [Schedule-III, VI, VIII] package No. UNOPS India/2nd line TB Drugs/55/2009 · 13 Apr 2010 · USD 265K · World Bank
- SUPPLY AND DELIVERY TUBERCULOSIS DRUGS - FIXED DOSE COMBINATIONS · 06 Apr 2010 · USD 442K · World Bank
- Procurement of First Line Anti TB Drugs [2008-09] Schedule-XXV · 20 Apr 2009 · USD 58K · World Bank
- PROCUREMENT OF TB 1ST LINE DRUGS - SCHEDULE 1 · 12 Mar 2008 · USD 751K · World Bank
- PROCUREMENT OF SECOND LINE TB DRUGS - SCHEDULE 1, 2, 3, 4, 5, 7, 8 · 05 Mar 2008 · USD 602K · World Bank
Method
Computed from 13 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.